Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy (Q35150629)

6 August 2017

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy (English)

1 reference

6 August 2017

1 reference

Robert L Giuntoli

1

1 reference

6 August 2017

Daniel S Metzinger

2

1 reference

6 August 2017

Connie S DiMarco

3

1 reference

6 August 2017

Stephen S Cha

4

1 reference

6 August 2017

Jeff A Sloan

5

1 reference

6 August 2017

Gary L Keeney

6

1 reference

6 August 2017

Bobbie S Gostout

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

89

1 reference

6 August 2017

3

1 reference

6 August 2017

460-469

1 reference

Sarcoma of the uterus. A clinical and pathologic study of 177 cases

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Leiomyosarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Uterine leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Uterine smooth-muscle tumors of uncertain malignant potential

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Resection of pulmonary metastases from uterine sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Uterine leiomyosarcoma: analysis of treatment failures and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Some recent developments for regression analysis of multivariate failure time data

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

A comparison of size and power calculations for the Wilcoxon statistic for ordered categorical data

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Mitotically active leiomyomas of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

The role of radiation therapy in the management of uterine sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Estradiol and progesterone receptors in gynecologic sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

Postoperative Nomogram for 12-Year Sarcoma-Specific Death

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900137-9

7 January 2021

10.1016/S0090-8258(03)00137-9

Identifiers

DOI

1 reference

6 August 2017

1 reference